UY24938A1 - Derivados de pirimidina y procedimientos para la preparación de los mismos - Google Patents

Derivados de pirimidina y procedimientos para la preparación de los mismos

Info

Publication number
UY24938A1
UY24938A1 UY24938A UY24938A UY24938A1 UY 24938 A1 UY24938 A1 UY 24938A1 UY 24938 A UY24938 A UY 24938A UY 24938 A UY24938 A UY 24938A UY 24938 A1 UY24938 A1 UY 24938A1
Authority
UY
Uruguay
Prior art keywords
pyrimidine
methyl
procedures
preparation
same
Prior art date
Application number
UY24938A
Other languages
English (en)
Spanish (es)
Inventor
Man Soon Hwang
Woo Jeon Shim
Song Jin Lee
Keun Seog Song
Seung Kyu Lee
Wook Lee Jong
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of UY24938A1 publication Critical patent/UY24938A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UY24938A 1997-03-27 1998-03-26 Derivados de pirimidina y procedimientos para la preparación de los mismos UY24938A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970010863 1997-03-27
KR19970010862 1997-03-27

Publications (1)

Publication Number Publication Date
UY24938A1 true UY24938A1 (es) 2001-01-31

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24938A UY24938A1 (es) 1997-03-27 1998-03-26 Derivados de pirimidina y procedimientos para la preparación de los mismos

Country Status (21)

Country Link
US (1) US6352993B1 (h)
EP (1) EP1015444B1 (h)
JP (1) JP3176379B2 (h)
KR (1) KR100278857B1 (h)
CN (1) CN1118464C (h)
AR (1) AR012181A1 (h)
AT (1) ATE241613T1 (h)
AU (1) AU720385B2 (h)
BR (1) BR9808070A (h)
CA (1) CA2284795C (h)
DE (1) DE69815126T2 (h)
DK (1) DK1015444T3 (h)
ES (1) ES2200324T3 (h)
HU (1) HUP0000851A3 (h)
IN (1) IN188411B (h)
PT (1) PT1015444E (h)
RU (1) RU2203894C2 (h)
TR (1) TR199902383T2 (h)
TW (1) TW542831B (h)
UY (1) UY24938A1 (h)
WO (1) WO1998043968A1 (h)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TW200302728A (en) 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
EP1534278A4 (en) 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
AU2004259346A1 (en) * 2003-07-22 2005-02-03 Neurogen Corporation Substituted pyridin-2-ylamine analogues
CA2541989C (en) * 2003-10-24 2013-10-01 Exelixis, Inc. P70s6 kinase modulators and method of use
WO2005041961A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
US20090124645A1 (en) * 2005-10-14 2009-05-14 Neurosearch A/S Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels
JP4946482B2 (ja) 2007-02-08 2012-06-06 船井電機株式会社 緩衝用梱包材及びｔｖ受像機の緩衝用梱包材
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
BRPI0917540A2 (pt) 2008-08-05 2015-11-17 Daiichi Sankyo Co Ltd composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
CA2817165A1 (en) 2010-11-15 2012-05-24 Patrick Chaltin Novel antiviral compounds
PL2678331T3 (pl) 2011-02-25 2016-12-30 Pochodne diaminopirymidyny i sposoby ich wytwarzania
CN104203939B (zh) * 2012-02-17 2017-06-06 艾伯维公司 用作人呼吸道合胞病毒（rsv）抑制剂的二氨基嘧啶
US9309271B2 (en) 2012-05-29 2016-04-12 Momentive Performance Materials Gmbh Preparation of isocyanato silanes
WO2014081906A2 (en) 2012-11-21 2014-05-30 Ptc Therapeutics, Inc. Substituted reverse pyrimidine bmi-1 inhibitors
EP2970307B1 (en) 2013-03-13 2020-03-11 Genentech, Inc. Pyrazolo compounds and uses thereof
EA034866B1 (ru) 2013-08-30 2020-03-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Замещенные пиримидиновые ингибиторы bmi-1
CN104903312B (zh) * 2013-10-07 2019-01-29 卡德门企业有限公司 Rho激酶抑制剂
US10584115B2 (en) 2013-11-21 2020-03-10 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine BMI-1 inhibitors
US10370360B2 (en) 2014-10-22 2019-08-06 The Board Of Regents Of The University Of Texas System Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
DK3400217T3 (da) * 2016-01-04 2022-06-07 Merck Serono Sa L-valinat af hydroxypropylthiazolidincarboxamid-derivat, dets salt og krystalform deraf
WO2018184978A1 (de) * 2017-04-05 2018-10-11 Bayer Cropscience Aktiengesellschaft 2-amino-5-oxyalkyl-pyrimidinderivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums
US12023335B2 (en) 2018-08-17 2024-07-02 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
FI95376C (fi) 1989-03-22 1996-01-25 Ciba Geigy Ag Mikrobisidiset 2-anilino-pyrimidiinijohdannaiset
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
US5444062A (en) 1990-11-06 1995-08-22 Pfizer Inc. Quinazolines derivatives for enhancing antitumor activity
DE69201559T2 (de) 1991-04-17 1995-07-13 Pfizer Pyrimidinderivate zur erhöhung der antitumoraktivität.
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
HUT75876A (en) * 1993-08-12 1997-05-28 Astra Ab Amidine derivatives with nitric oxide synthetase activities, pharmaceutical compositions containing them and process for their preparation
DK0640599T3 (da) 1993-08-26 1998-09-28 Ono Pharmaceutical Co 4-Aminopyrimidin-derivater
RU2153494C2 (ru) 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
ES2201112T3 (es) 1994-08-13 2004-03-16 Yuhan Corporation Nuevos derivados de pirimidina y procedimientos para su preparacion.
CA2358479C (en) * 1996-05-04 2004-07-13 Yuhan Corporation 4-substituted-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine

Also Published As

Publication number Publication date
CN1118464C (zh) 2003-08-20
CA2284795A1 (en) 1998-10-08
JP2000513014A (ja) 2000-10-03
IN188411B (h) 2002-09-21
AU6523998A (en) 1998-10-22
US6352993B1 (en) 2002-03-05
HK1026418A1 (en) 2000-12-15
EP1015444A1 (en) 2000-07-05
TR199902383T2 (xx) 2000-06-21
TW542831B (en) 2003-07-21
RU2203894C2 (ru) 2003-05-10
BR9808070A (pt) 2000-03-08
AU720385B2 (en) 2000-06-01
KR19980080789A (ko) 1998-11-25
WO1998043968A1 (en) 1998-10-08
CA2284795C (en) 2004-01-20
DE69815126T2 (de) 2004-04-08
EP1015444B1 (en) 2003-05-28
JP3176379B2 (ja) 2001-06-18
HUP0000851A3 (en) 2002-04-29
HUP0000851A1 (hu) 2001-04-28
AR012181A1 (es) 2000-09-27
ATE241613T1 (de) 2003-06-15
CN1251586A (zh) 2000-04-26
PT1015444E (pt) 2003-10-31
KR100278857B1 (ko) 2001-01-15
ES2200324T3 (es) 2004-03-01
DE69815126D1 (de) 2003-07-03
DK1015444T3 (da) 2003-08-18

Similar Documents

Publication Publication Date Title
UY24938A1 (es) Derivados de pirimidina y procedimientos para la preparación de los mismos
CO4770975A1 (es) Derivados de quinazolina sustituidos
EP0638567A4 (en) ADENOSINE INHIBITORS.
AR082864A2 (es) Preparacion de compuestos de aminopirimidina
AR021534A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica
PE20040647A1 (es) Inhibidores de cinasas de tirosina
AR021533A1 (es) Derivados de 2,5-diazabiciclo[2.2.1]heptano, su preparacion y su aplicacion en terapeutica
DK1150714T3 (da) Fremgangsmåder til inhibering af hjernetumorvækst
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
BG103258A (en) Azinyloxy- and phenoxydiaryl derivatives of carboxylic acids, their preparation and application as mixed eta/etb endothelin-receptor antagonists
ES2039242T3 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
AR028648A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano-fenilisoxazol, su preparacion y su aplicacion en terapéutica
AR028649A1 (es) Derivados de 4-(2-feniltiazol-5-il)-1,4-diazabiciclo [3.2.2]nonano, su preparacion y su aplicacion en terapéutica
SE0101579D0 (sv) New compounds
CO4970840A1 (es) Ciertas 1-(2-naftil) y 1-(azanaftil)-4-(1-fenilmetil) pipe- razinas; ligandos especificos del subtipo receptor de la dopamina
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
ES2151254T3 (es) Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2.
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
FI851611A0 (fi) Heterocykliska aminokomponenter.
CO5011110A1 (es) Nuevos derivados de 2-(3h)-oxazolona
CO4940417A1 (es) DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
CO5031252A1 (es) Compuestos
ATE119523T1 (de) Isochinolinderivate und ihre salze als proteasehemmer.
CO4940439A1 (es) COMPUESTOS 4-AMINO-6,7-DISUSTITUIDOS-PIRIDO-[2,3-d] PIRIMI- DINA
ES2065992T3 (es) Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20180326